GMP IPO
📋 Filings Intelligence
About Contact
LIVE — Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement — financial results, order wins, dividends, mergers and more. Updated live.

—
Filed today
—
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings —

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Valiant Laboratories Ltd

Valiant Laboratories Reports Q2 FY27 Standalone Net Profit at Rs. 132.58 Lakhs

RESULTS ▲ Positive Development MEDIUM RISK
📅 Filed on BSE: 02 Nov 2026, 07:01 PM IST  ·  BSE ID: e43c0512-85c0-4ac5-8bb2-422cd0ccbd81
View Original BSE Filing (PDF)
💡
In Simple Terms
Valiant Laboratories' Q2 FY27 earnings show a standalone net profit of Rs. 132.58 Lakhs.
🤖 AI Summary
  • Valiant Laboratories Board approved Audited Standalone and Consolidated Financial Results for Q2 FY27.
  • Standalone Total Income From Operations for the quarter ended 30 September 2026 was Rs. 7,73.48 Lakhs.
  • Standalone Net Profit After Tax for Q2 FY27 reached Rs. 132.58 Lakhs.
  • Basic Earnings per Equity Share for the quarter stood at Rs. 0.02.
  • Raman S. Shah & Co., Chartered Accountants, provided the audit report for the financial results.
🔢 Key Numbers — exact figures from BSE filing, not rounded
Total Income From Operations (Q2 FY27)
Rs. 7,73.48 Lakhs
Not comparable — limited prior period data.
Net Profit After Tax (Q2 FY27)
Rs. 132.58 Lakhs
Not comparable — limited prior period data.
Basic Earnings per Equity Share (Q2 FY27)
Rs. 0.02
Not comparable — limited prior period data.
Total Income From Operations (Half Year Ended 30 Sep 2026)
Rs. 1,441.50 Lakhs
Not comparable — limited prior period data.
Net Profit After Tax (Half Year Ended 30 Sep 2026)
Rs. 229.58 Lakhs
Not comparable — limited prior period data.
Paid up equity share capital
543125 Lakhs
🏢 How This Affects the Company
📈
Business Impact
The company reported Total Income From Operations of Rs. 7,73.48 Lakhs for Q2 FY27 and Rs. 1,441.50 Lakhs for the half year ended 30 September 2026.
💰
Financial Impact
Standalone Net Profit After Tax was Rs. 132.58 Lakhs for Q2 FY27 and Rs. 229.58 Lakhs for the half year ended 30 September 2026.
👥 What This Means For Shareholders
✅
Action Required
No specific action is required from shareholders based on this financial results filing.
👤
Who Is Affected
All shareholders are affected by the company's financial performance, as reflected in the Q2 FY27 standalone net profit of Rs. 132.58 Lakhs.
🔍
Management Signal
Management is focused on maintaining profitability and complying with regulatory financial reporting standards.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events
Q3 FY27 financial results — check revenue and profit trends.
Any updates on operational expansion or new product developments.
Annual General Meeting (AGM) announcements for management commentary.
MEDIUM RISK Relatively early operational history makes consistent performance and growth sustainability a point for observation.
💡 Investor Takeaway
Valiant Laboratories reported a Standalone Net Profit After Tax of Rs. 132.58 Lakhs for Q2 FY27, with Total Income From Operations at Rs. 7,73.48 Lakhs. For the half year ended 30 September 2026, standalone net profit was Rs. 229.58 Lakhs, on Total Income From Operations of Rs. 1,441.50 Lakhs.
⚖️ Strengths & Concerns

✅ Positives

  • Standalone Net Profit After Tax for Q2 FY27 was Rs. 132.58 Lakhs, indicating profitability for the quarter.
  • Total Income From Operations for the half year ended 30 September 2026 reached Rs. 1,441.50 Lakhs.

⚠️ Concerns

  • Basic Earnings per Equity Share remained low at Rs. 0.02 for Q2 FY27.
  • Total Income From Operations for Q2 FY27 decreased from Rs. 7,72.24 Lakhs in Q1 FY27 to Rs. 7,73.48 Lakhs.
📅 Company Track Record
Valiant Laboratories was incorporated in 2021 and recently listed. The company reported standalone net profit of Rs. 554.82 Lakhs for FY26 and Rs. 132.58 Lakhs for Q2 FY27, showing a trend of positive profitability since its listing.

Based on publicly available historical data. For context only.

❓ Frequently Asked Questions
What was Valiant Laboratories' standalone net profit for Q2 FY27?
Valiant Laboratories reported a standalone Net Profit After Tax of Rs. 132.58 Lakhs for the quarter ended 30 September 2026 (Q2 FY27).
What was Valiant Laboratories' Total Income From Operations for the half year ended 30 September 2026?
The Total Income From Operations for Valiant Laboratories for the half year ended 30 September 2026 was Rs. 1,441.50 Lakhs.
What was the Basic Earnings per Equity Share for Valiant Laboratories in Q2 FY27?
The Basic Earnings per Equity Share for Valiant Laboratories for the quarter ended 30 September 2026 (Q2 FY27) was Rs. 0.02.
Who audited the financial results for Valiant Laboratories?
The Audited Standalone and Consolidated Financial Results for Valiant Laboratories were audited by Raman S. Shah & Co., Chartered Accountants.

Questions based on this BSE filing only. For information purposes.

You've read one filing

There are 32,000 more, and one of them is about a company you own

Follow a company and we'll email you the moment it files again — explained, not just forwarded. Free.

  • Follow companies and get filings by email
  • Save any filing to read later
  • Two full AI analyses every month, free

No card needed. Sign in with Google in two taps.

⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.